Death is associated to the type of drug-eluting stent in patients with left ventricular dysfunction and elevated natriuretic peptide levels
Abstract As advanced heart failure (HF) with elevated NT-proBNP is characterized by an activated coagulation system, coronary events clinically noticed as sudden or HF death may be more common after treatment with first- compared to newer-generation DES. Our study evaluates (1) if patients with left...
Enregistré dans:
Auteurs principaux: | Christian Roth, Clemens Gangl, Walter S. Speidl, Georg Goliasch, Matthias Schneider, Daniel Dalos, Rudolf Berger |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/0c8ae0d5ccd840b382c9f9eb0f930b19 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Everolimus-eluting coronary stents
par: Alejandro Saez, et autres
Publié: (2010) -
Subclinical Left Ventricular Dysfunction During Chemotherapy
par: Martin Nicol, et autres
Publié: (2019) -
Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction
par: Piotr Desperak, et autres
Publié: (2020) -
Very Long-term Safety and Effectiveness of Drug-Eluting or Bare-Metal Stents for Left Main Coronary Disease
par: Hanbit Park, MD, et autres
Publié: (2021) -
Computational and experimental mechanical performance of a new everolimus-eluting stent purpose-built for left main interventions
par: Saurabhi Samant, et autres
Publié: (2021)